| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±2.4% | +2.7% | under-priced |
| 04/30/2026 | ±2.6% | +0.9% | over-priced |
| 02/24/2026 | ±3.1% | +0.7% | over-priced |
| 10/30/2025 | ±1.9% | -0.3% | over-priced |
| 07/30/2025 | ±3.0% | -0.1% | over-priced |
| 04/30/2025 | ±2.8% | -0.1% | over-priced |
| 02/24/2025 | ±2.1% | -0.1% | over-priced |
| 10/29/2024 | ±3.5% | +0.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | — | $2.7B | $792M |
| Q1 FY2026 | $2.71 | $2.2B | $526M |
| Q4 FY2025 | — | $2.1B | $466M |
| Q3 FY2025 | $2.29 | $2.0B | $458M |
Northern Trust Corporation Common Stock (NTRS) reports in 2 days, with the next report estimated for 10/29/2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 0.7% on average — the market has systematically over-priced NTRS's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 35.0%. QuantLogix's live 5-factor engine currently reads NTRS as a buy at 60/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →